Table 2.
Baseline |
Following 3 mos of treatment |
Difference of | Significance |
|||||||
---|---|---|---|---|---|---|---|---|---|---|
Mean | Min. | Max. | n | Mean | Min. | Max. | n | the means | P-value | |
25(OH)D (nmol/L) | 20.0 | 10 | 38 | 21 | 61.3 | 36 | 119 | 19 | 41.3 | <0.001 |
PTH (nmol/L) | 80.4 | 22 | 175 | 21 | 47.3 | 18 | 110 | 21 | −33.1 | 0.004 |
Rated pain in VAS (cm) | 5.7 | 2 | 10 | 19 | 3.2 | 0 | 7 | 18 | −2.5 | 0.005 |
Chair stand test (s) | 23.4 | 12 | 37 | 21 | 19.7 | 11 | 29 | 20 | −3.7 | <0.001 |
Bone tenderness (kPa) | 567.7 | 210 | 876 | 17 | 542.5 | 239 | 882 | 0 | −25.2 | 0.470 |
VAS, visual analogue scale; PTH, parathyroid hormone; 25(OH)D, 25-hydroxyvitamin D.